SCIENTIFIC PROGRAMThe Liver Week 2020 Virtual Conference

The Liver Week 2020 Virtual Confernence [DAY 2: Friday, August 14, 2020]

PROGRAM BOOK DOWNLOAD

08:30-10:50

Real Time Discussion

Policy Symposium. Nationwide Policies to Eliminate Hepatitis C
Dong Jin Suh (Korean Liver Foundation), W. Ray Kim (Stanford Univ., USA), Han Chu Lee (Univ. of Ulsan)
08:30-09:00
Hepatitis C Elimination Program in Taiwan: “The Taiwan Hepatitis C Policy Guideline 2018 - 2025”Chien-Jen Chen (Former Vice President of Taiwan, Academia Sinica, Taiwan)
09:00-09:20
HCV Elimination in Taiwan: What and How We Have Achieved from the Beginning till TodayJia-Horng Kao (National Taiwan Univ., Taiwan)
09:20-09:40
HCV Elimination in Japan: The Japanese Policy and OutcomeTatsuya Kanto (National Center for Global Health and Medicine, Japan)
09:40-10:00
National Policies on Hepatitis C in KoreaHyung-Min Lee (Korea Centers for Disease Control & Prevention)
10:00-10:20
Current Status and Suggestions for Hepatitis C Control in KoreaDo Young Kim (Yonsei Univ.)
10:20-10:50
Panel Discussion
08:30-10:20

Real Time Discussion

ISALPDC 3. Alcohol Promotion of Cancer
Wen Xing Ding (Univ. of Kensas, USA), Yingzi Yang (Harvard Univ., USA)
08:30-08:50
Hippo Pathway Regulation of Liver Inflammation and CancerYingzi Yang (Harvard Univ., USA)
08:50-09:10
Complement C3, tRNA-derived Fragments Gly-tRFs, and Alcoholic Liver DiseaseSongqing He (Guangxi Medical Univ., China)
09:10-09:30
Autophagy and CancerWen-Xing Ding (Univ. of Kensas, USA)
09:30-09:50
Risk Factors for Alcohol-Related Hepatocellular CarcinomaMakiko Taniai (Tokyo Women’s Medical Univ., Japan)
09:50-10:00
Catecholamine Signaling Pathway Protects Alcoholic Fatty Liver by Inducing Growth Differentiation Factor 15Hee-Hoon Kim (KAIST)
10:00-10:20
Round Table Discussions
08:50-09:50
Basic Science Workshop
08:30-08:50
Transcriptomic Signature of Nonalcoholic Fatty Liver DiseaseMurim Choi (Seoul National Univ.)
08:50-09:10
Immunologic Circuits of Hepatocellular CarcinomaSu Jong Yu (Seoul National Univ.)
09:10-09:30
Interactive Interface between Gut Microbiome and Immunome in Alcohol-Related Liver DiseaseBernd Schnabl (Univ. of California San Diego, USA)
09:30-09:50
Novel Immunomodulating Pharmabiotics for Hepatocellular CarcinomaHan Soo Park (GIST)
09:50-10:50
Special Interest Group Forum. Clinical Issues in Autoimmune Liver Disease
09:50-10:10
Pathology of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Overlap SyndromeMasayoshi Kage (Kurume Univ., Japan)
10:10-10:30
Autoimmune Hepatitis: From Bench to ClinicXiong Ma (Shanghai Jiao Tong Univ., China)
10:30-10:50
Primary Biliary Cholangitis: Unsolved Issues and New TreatmentGideon M. Hirschfield (Univ. of Birmingham, UK)
10:30-12:45

Real Time Discussion

ISALPDC 4. Translational Studies and Public Health on Alcoholic Liver Disease
Shiv Kumar Sarin (Institute of Liver and Biliary Science, India), Suthat Liangpunsakul (Indiana Univ., USA)
10:30-10:50
Prognostic Potential of LncRNAs for Alcoholic Liver Disease PatientsSuthat Liangpunsakul (Indiana Univ., USA)
10:50-11:10
Predictors of Steroid Non-Response and New Approaches in Severe Alcoholic HepatitisShiv Kumar Sarin (Institute of Liver and Biliary Science, India)
11:10-11:30
Global and Regional Impacts of Alcohol Use on Public HealthDong Joon Kim (Hallym Univ.)
11:30-11:50
Impact of Genetic Traits and Drinking Mode on Alcoholic Liver Disease in ChinaJia Xiao (Fujian Normal Univ., China)
11:50-12:10
TAPPY: Multi-Professional Care of Alcoholic PatientsMasahiro Kikuchi (Tokyo Medical Center, Japan)
12:10-12:20
The Evolution of Liver Donor Liver Transplantation for Alcoholic Liver Cirrhosis in a High-Volume Center: The Eastern Perspective Jeffrey Samuel Co (Kaohsiung Chang Memorial Hospital, Taiwan)
12:20-12:40
Round Table Discussions
12:40-12:45
Closing Remarks
11:00-12:00

Real Time Discussion

Plenary Presentation 2
Jin Mo Yang (The Catholic Univ. of Korea), Chul Ju Han (Korea Cancer Center Hospital), Yang Won Nah (Univ. of Ulsan)
12:10-12:55
Satellite Symposium 4 Yuhan
12:10-12:55
Satellite Symposium 5 Eisai
12:10-12:55
Satellite Symposium 6 BMS
13:00-14:10

Real Time Discussion

KLTS-KAHBPS-KLCA Joint Symposium. Treatment Options for HCC beyond the Milan Criteria in Patients with Marginal Liver Function
Jong Young Choi (The Catholic Univ. of Korea), Shin Hwang (Univ. of Ulsan)
13:00-13:20
Locoregional TherapyYoon Jun Kim (Seoul National Univ.)
13:20-13:40
Down-Staging Living Donor Liver TransplantationJae Geun Lee (Yonsei Univ.)
13:40-14:00
Is There a Role for TKIs and Immune Checkpoint Inhibitors?Thomas Yau (Univ. of Hong Kong, China)
14:00-14:10
Discussion
13:00-14:00
KLCA Symposium 2. Updates in Diagnosis and Biomarkers of Hepatocellular Carcinoma
13:00-13:20
Established and Potential Biomarkers of Hepatocellular Carcinoma with Focus on Recent Clinical TrialsJoong-Won Park (National Cancer Center Korea)
13:20-13:40
Imaging Biomarkers in the Era of Precision MedicineSun Young Lee (Yonsei Univ.)
13:40-14:00
Pathologic Biomarkers that Indicate the Aggressiveness and Prognosis of Hepatocellular CarcinomaYoung Nyun Park (Yonsei Univ.)
13:30-14:40

Real Time Discussion

General Oral Presentation 2
Young Oh Kweon (Kyungpook National Univ.), Sang-Jae Park (National Cancer Center Korea )
14:10-15:10
KAHBPS-KLTS Joint Symposium. Optimal Use of ICG Fluorescence Technology in Daily Practice
14:10-14:30
Tumor Localization in Oncologic Surgery Masaki Ueno (Wakayama Medical Univ., Japan)
14:30-14:50
Anatomical Liver ResectionDai Hoon Han (Yonsei Univ.)
14:50-15:10
Donor HepatectomyYoung Rock Choi (Seoul National Univ.)
14:20-15:20

Real Time Discussion

KASL Plenary Presentation
Seong Gyu Hwang (CHA Univ.), Kwon Yoo (Ewha Womans Univ.)
14:40-15:25
Satellite Symposium 7 ILDONG
15:20-16:40
KASL Symposium 3. Exploration of Biomarkers in Liver Diseases
15:20-15:40
New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B InfectionIl Han Song (Dankook Univ.)
15:40-16:00
Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver DiseaseSuthat Liangpunsakul (Indiana Univ., USA)
16:00-16:20
Quantitative Imaging Biomarker in the Assessment of Hepatic Fibrosis and SteatosisWoo Kyoung Jeong (Sungkyunkwan Univ.)
16:20-16:40
Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular CarcinomaSoo Young Park (Kyungpook National Univ.)
15:30-17:00

Real Time Discussion

KASL-KAHBPS-KLTS Joint Symposium. How to Improve Outcome in Critically Ill Patients Awaiting Liver Transplantation
Soon Ho Um (Korea Univ.), Hee Chul Yu (Chonbuk National Univ.)
15:30-15:50
Liver Transplantation for Patients with Severe Alcoholic Hepatitis: Inside Stories of Patient Selection and Pretransplant ManagementPhilippe Mathurin (Chu De Lille, France)
15:50-16:10
Risk Stratification and Optimal Management for Liver Transplantation in Acute-on-Chronic Liver FailureDong Hyun Sinn (Sungkyunkwan Univ.)
16:10-16:30
Risk Stratification and Optimal Management for Liver Transplantation in Acute Liver Failure Young-dong Yu (Korea Univ.)
16:30-16:50
How to Improve Post-Transplant Outcomes in Patients with High MELD Scores Dong-Hwan Jung (Univ. of Ulsan)
16:50-17:00
Discussion
17:00-17:30
Closing and Award Ceremony